focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksChamberlin Plc Regulatory News (CMH)

  • This share is currently suspended. It was suspended at a price of 1.18

Share Price Information for Chamberlin Plc (CMH)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1.18
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 0.00 (0.00%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 1.18
CMH Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update

10 Apr 2024 07:00

RNS Number : 9300J
Chamberlin PLC
10 April 2024
 

10 April 2024

 

Chamberlin plc

("Chamberlin", the "Company" or the "Group")

 

Trading Update

 

Chamberlin plc (AIM: CMH.L), the specialist castings and machining group, announces a trading update in respect of the three-month period ending 29 February 2024 ("Q3 FY24") and outlook for the final quarter of FY24 ending 31 May 2024 ("Q4 FY24").

 

Underlying demand across the Group during Q3 FY24 was below management's expectations. Schedules over the period were lower than previously forecast by our customers and were further impacted by delays with the startup of certain new programs. Encouragingly, demand from customers in the renewable offshore energy market remained very strong, but the majority of other market sectors were affected by a slowdown in immediate demand.

 

Lower sales during Q3 FY24 have negatively affected profitability and working capital, however the management team are taking appropriate action to mitigate the impact now and going forward.

 

The slowdown has started to improve during Q4 FY24 and customer schedules are recovering to a more normalised and stable level, with a strong uptick in demand forecast within the next 6-month period as new programs start to ramp up production.

 

Following a full strategic review, a program of cost reduction actions have been implemented across the Group including labour reductions, short time working (as required) and senior management restructuring. Alongside this, the Company has conducted a full review of product margins and implemented price increases accordingly to underpin the required profitability and cash generation. The Group is expected to benefit from these actions within 3 months and create a more robust level of profitability going forward.

 

As previously announced, balance sheet debt following the sale of Petrel Ltd has greatly improved and the Company remains focused on paying off the remainder of its legacy debt within the next 12-month period (excluding the remaining pension deficit and HSBC invoice finance facility). Working capital levels are being monitored closely following recent performance and the steps being taken by the management team are expected to improve this position going forward.

 

The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulation (EU) No. 596/2014 as it forms part of United Kingdom domestic law by virtue of the European Union (Withdrawal) Act 2018.

 

Enquiries:

 

Chamberlin plc

Kevin Price, Chief Executive

Alan Tomlinson, Finance Director

 

 

T: 01922 707100

Cavendish Capital Markets Limited

(Nominated Adviser and Joint Broker)

Katy Birkin

Stephen Keys

George Lawson

 

 

T: 020 7220 5500

Peterhouse Capital Limited

(Joint Broker)

Lucy Williams

Duncan Vasey

T: 020 7469 0930

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTUPUBCCUPCGQB
Date   Source Headline
9th Mar 20213:13 pmRNSHolding(s) in Company
8th Mar 20211:30 pmRNSResult of Meeting and Directorate Change
19th Feb 20217:00 amRNSConvertible Loan and Notice of General Meeting
21st Jan 20217:00 amRNSTrading Statement
4th Jan 20217:30 amRNSSuspension - Chamberlin Plc
18th Dec 20205:43 pmRNSPublication of Audited Accounts
16th Dec 202011:55 amRNSTrading Update
27th Nov 20207:00 amRNSPublication of Audited Accounts
24th Nov 20207:15 amEQSHardman & Co Research: Chamberlin (CMH): Trading update ‒ main businesses performing solidly
23rd Nov 20207:00 amRNSTrading Update
6th Nov 20207:00 amRNSPublication of Audited Accounts
29th Sep 202010:42 amEQSHardman & Co Research: Chamberlin (CMH): Trading update most encouraging
29th Sep 20207:00 amRNSPublication of 2020 Accounts and Trading Update
23rd Jul 20205:48 pmRNSHolding(s) in Company
19th Jun 202012:15 pmRNSTrading Update
30th Mar 202012:45 pmEQSHardman & Co Research: Chamberlin Plc (CMH): Trading stalled in these unprecedented times
27th Mar 20202:24 pmRNSTrading Update
18th Feb 20203:20 pmRNSHolding(s) in Company
17th Feb 20202:00 pmRNSHolding(s) in Company
17th Feb 202011:52 amEQSHardman & Co Research: Chamberlin Plc (CMH): Near-term trading subdued
13th Feb 20205:53 pmRNSTrading Statement
6th Dec 20197:01 amRNSContract award for Walsall foundry
6th Dec 20197:00 amRNSContract award for Scunthorpe foundry
22nd Nov 20197:00 amRNSHolding(s) in Company
19th Nov 201911:55 amEQSHardman & Co Research: Chamberlin Plc (CMH): Management actions yield cautious optimism
18th Nov 20197:00 amRNSHalf-year Report
4th Nov 20197:00 amRNSNotice of Interim Results
21st Oct 20191:01 pmRNSHolding(s) in Company
18th Oct 20197:00 amRNSHolding(s) in Company
23rd Jul 20194:05 pmRNSResult of AGM
23rd Jul 20197:00 amRNSBoard Retirement
23rd Jul 20197:00 amRNSAGM Statement
19th Jun 201910:14 amRNSHolding(s) in Company
4th Jun 20197:31 amEQSHardman & Co Research: Chamberlin (CMH): Trading remains difficult; forecasts lowered
4th Jun 20197:00 amRNSFinal Results
30th May 201912:35 pmRNSTrading Update
21st Feb 20192:23 pmRNSHolding(s) in Company
6th Feb 20192:06 pmEQSHardman & Co Research: Chamberlin (CMH): Trading very difficult; forecasts lowered
5th Feb 20197:52 amRNSTrading Update
24th Dec 20187:00 amRNSHalf-year Report
20th Dec 20187:00 amRNSSale of Exidor Limited
12th Dec 20187:00 amRNSChange of Adviser
12th Nov 20187:00 amRNSAppointment of Finance Director
2nd Aug 20187:00 amRNSDirectorate Change
24th Jul 20182:57 pmRNSResult of AGM
24th Jul 20187:00 amRNSAGM Statement
19th Jun 20183:39 pmRNSGrant of Options
5th Jun 201811:45 amEQSHardman & Co Research: Chamberlin pLC (CMH): Trading strong, technical issues largely resolved
5th Jun 20187:00 amRNSFinal Results
9th May 20186:05 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.